$IONQ

Analysts Are Bullish on Top Technology Stocks: IonQ (IONQ), Klaviyo, Inc. Class A (KVYO)

Analysts reiterated Buy ratings on IonQ (IONQ) and Klaviyo (KVYO). IonQ's price target set at $60.00 by Craig-Hallum, with consensus at $67.36. Klaviyo's target set at $28.00 by Cantor Fitzgerald, with consensus at $26.50. Both stocks have Strong Buy consensus.

Original reporting
Published Sep 11, 2026, 1:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 4:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Are Bullish on Top Technology Stocks: IonQ (IONQ), Klaviyo, Inc. Class A (KVYO) — source image
Decision brief

The 30-second read

$IONQBullishMed
01

Why it matters

New coverage could trigger short‑term buying pressure, but the effect depends on broader market risk appetite.

02

Market read

Analyst upgrades provide fresh catalysts for two small‑cap tech stocks, offering short‑term trade ideas.

03

What to watch

Both firms face execution risk and competitive pressure that could temper price gains.

Relevance 6/10Novelty 5/10Timing: today

Background

The article aggregates two fresh analyst opinions on high‑growth technology companies.

Company-level read

Ticker impact

$IONQBullishMedium confidence
Context

Craig-Hallum reiterated a Buy rating and set a $60 price target for IonQ, providing fresh analyst coverage.

Expected impact

Potential upside of ~60% from current price.

Evidence & confidence

Buy rating and $60 target represent a sizable upside; investors may buy on the new endorsement.

$KVYOBullishMedium confidence
Context

Cantor Fitzgerald maintained a Buy rating and set a $28 price target for Klaviyo, adding fresh analyst support.

Expected impact

Potential upside of ~70% from current price.

Evidence & confidence

Analyst endorsement with a sizable target increase may attract buying interest.

Market effects

Positive analyst sentiment may lift other quantum‑computing and SaaS names.

U.S. tech sector may see modest gains.

Limited to investors tracking high‑growth tech stocks.

Counterpoint

Analyst targets may be overly optimistic given recent volatility in quantum and marketing‑automation stocks.

Key entities

  • Craig‑Hallum

    Senior analyst who reaffirmed a Buy on IonQ.

  • Matthew VanVliet

    Cantor Fitzgerald analyst who maintained a Buy on Klaviyo.

Related articles

$IONQHighAI 8/10

Why Did IonQ Stock Gain in After-Hours Trading on Wednesday?

IonQ's stock rose 1.17% in after-hours trading after advancing to the final stage of DARPA's Quantum Benchmarking Initiative, with a potential $300M agreement for testing its quantum systems through 2029. The program aims to assess the practicality of quantum computing by 2033. IonQ is one of four companies selected for this stage, with a Strong Buy consensus and an average price target of $71.

$IONQMed

IonQ Advances to Stage C in DARPA Quantum Initiative, Shares Tra

IonQ Inc. (NYSE: IONQ) advanced to Stage C in DARPA's Quantum Benchmarking Initiative, securing a potential $300M agreement. The company's P/S ratio is 59.44, below its historical median of 138.4x. IonQ has a GF Score of 47/100, indicating mixed fundamentals. Insiders have sold more shares than they've bought in the past year, while institutional ownership remains steady.

$IONQMed

IonQ DARPA Stage C: $300M Is the Program’s Published Cap

IonQ (NYSE: IONQ) announced it reached Stage C of DARPA's Quantum Benchmarking Initiative with a potential $300M agreement. The deal's exact funding is undisclosed, matching DARPA's published Stage C cap. Testing of IonQ's Superion systems will continue through 2029. DARPA's Stage C evaluates companies' readiness for utility-scale quantum computer design and construction.

$IONQHigh

IonQ advances to Stage C of DARPA quantum benchmarking program under deal worth up to USD 300 million

IonQ advanced to Stage C of DARPA's Quantum Benchmarking Initiative, triggering a deal potentially worth up to $300 million. The program, running through 2029, will validate IonQ's approach to large-scale fault-tolerant quantum computing. IonQ's sixth-generation system, Superion 256, is the current platform for its scaling plans, according to the company.

$IONQMed

IonQ advances in DARPA quantum program, secures $300M deal

IonQ Inc. (NYSE: IONQ) advanced to Stage C of DARPA's Quantum Benchmarking Initiative, securing a deal potentially worth $300M. The program evaluates quantum computing systems for utility scale. Stage C involves DARPA testing IonQ's Superion systems through 2029. IonQ plans to scale manufacturing and expand customer base in various sectors.